Gastroduodenal disorders of gut-brain interaction: Practical implications of Rome V in Latin America

Authors

DOI:

https://doi.org/10.22516/25007440.1616

Keywords:

Rome V, postprandial distress syndrome, epigastric pain syndrome, Helicobacter pylori, Latin America, dyspepsia, gut-brain axis

Abstract

Introduction: Rome V redefines aspects of the conceptual framework and classification of disorders of gut-brain interaction (DGBIs). In gastroduodenal disorders (GDDs), it introduces changes with important implications for clinical practice, including improved characterization of functional dyspepsia (FD), greater differentiation of its symptom-based subtypes, and updated definitions of other GDDs. The objective is to review the principal updates introduced by Rome V for GDDs, with particular emphasis on FD, and to discuss their clinical applicability in Latin America.

Results: Rome V places greater emphasis on the subtypes of FD, specifically postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS), and broadens the spectrum of PDS by including additional meal-related symptoms that were not previously considered part of its definition. These changes improve diagnostic characterization and support a symptom profile–guided therapeutic approach. Rome V reinforces the concept of positive diagnosis and the rational use of ancillary investigations, including upper gastrointestinal endoscopy; furthermore, it distinguishes Helicobacter pylori-associated dyspepsia from FD and updates the classification of other GDDs.

Conclusions: Rome V consolidates a more precise and individualized clinical approach to GDDs. Its recommendations are consistent with the recent Latin American Consensus on FD and can be adapted to different healthcare settings through a more detailed clinical assessment of patients.

Downloads

Download data is not yet available.

Author Biography

Ignacio Hanna Jairala, Hospital Alcívar

Staff Physician, Department of Internal Medicine, Gastroenterology Service, Hospital Miguel H. Alcívar, Guayaquil, Ecuador.

References

Drossman DA, Chang L, Tack J. Disorders of Gut–Brain Interaction and the Rome V Process. Gastroenterology. 2026;170(6):1083-98. https://doi.org/10.1053/j.gastro.2026.02.014

Törnblom H, Carbone F, Hasler WL, Smout A, Suzuki H, Tack J, et al. Gastroduodenal Disorders. Gastroenterology. 2026;170(6):1240-60. https://doi.org/10.1053/j.gastro.2026.01.038

Drossman DA, Tack J. Rome Foundation Clinical Diagnostic Criteria for Disorders of Gut-Brain Interaction. Gastroenterology. 2022;162(3):675-9. https://doi.org/10.1053/j.gastro.2021.11.019

Remes-Troche JM, Aguilar-Paiz L, Carmona-Sánchez R, Coss-Adame E, Hanna-Jairala I, Valdovinos-Díaz MA, et al. Consenso latinoamericano para el diagnóstico y tratamiento de la dispepsia funcional. Rev Gastroenterol México. https://doi.org/10.1016/j.rgmx.2026.07.004.

Sperber AD. The Rome Foundation Global Epidemiology study: Conception, implementation, results, and future potential. Neurogastroenterol Motil. 2023;35(6):e14567. https://doi.org/10.1111/nmo.14567

Schmulson MJ, Puentes-Leal GA, Bustos-Fernández L, Francisconi C, Hani A, López-Colombo A, et al. Comparison of the epidemiology of disorders of gut–brain interaction in four Latin American countries: Results of The Rome Foundation Global Epidemiology Study. Neurogastroenterol Motil. 2023;35(6):e14569. https://doi.org/10.1111/nmo.14569

Pinto‐Sanchez MI, Yuan Y, Hassan A, Bercik P, Moayyedi P. Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev. 2017;2017(11):CD011194. https://doi.org/10.1002/14651858.CD011194.pub3

Hanna-Jairala I, Schmulson MJ. Treatment of functional dyspepsia beyond proton pump inhibitors. Neurogastro Latam Reviews. 2025;9:108-119. https://doi.org/10.24875/NGL.25000002

Ford AC, Luthra P, Tack J, Boeckxstaens GE, Moayyedi P, Talley NJ. Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut. 2017;66(3):411-20. https://doi.org/10.1136/gutjnl-2015-310721

Zhou W, Li X, Huang Y, Xu X, Liu Y, Wang J, et al. Comparative efficacy and acceptability of psychotropic drugs for functional dyspepsia in adults. Medicine (Baltimore). 2021;100(20):e26046. https://doi.org/10.1097/MD.0000000000026046

Hanna-Jairala I, Tack J, Drossman DA. Central and Peripheral Neuromodulators in Functional Dyspepsia and Gastroparesis: A Symptom-Based Clinical Review. Neurogastroenterol Motil. 2026;38(3):e70278. https://doi.org/10.1111/nmo.70278

Qi Q, Wang N, Liu H, Li Y. Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis. BMC Gastroenterol. 2023;23(1):370. https://doi.org/10.1186/s12876-023-03014-9

Ford AC, Moayyedi P, Black CJ, Yuan Y, Veettil SK, Mahadeva S, et al. Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia. Aliment Pharmacol Ther. 2020;53(1):8-21. https://doi.org/10.1111/apt.16072

Huang X, Lv B, Zhang S, Fan YH, Meng LN. Itopride therapy for functional dyspepsia: A meta-analysis. World J Gastroenterol WJG. 2012;18(48):7371-7. https://doi.org/10.3748/wjg.v18.i48.7371

Shrestha DB, Budhathoki P, Subedi P, Khadka M, Karki P, Sedhai YR, et al. Acotiamide and Functional Dyspepsia: A Systematic Review and Meta-Analysis. Cureus. 13(12):e20532. https://doi.org/10.7759/cureus.20532

Ali H, Pamarthy R, Sarfraz S. Role of Prucalopride in Treating Functional Constipation and Gastroparesis: A Systemic Review. Cureus. 2021;13(4):e14306. https://doi.org/10.7759/cureus.14306

Tack J, Janssen P, Masaoka T, Farré R, Oudenhove LV. Efficacy of Buspirone, a Fundus-Relaxing Drug, in Patients With Functional Dyspepsia. Clin Gastroenterol Hepatol. 2012;10(11):1239-45. https://doi.org/10.1016/j.cgh.2012.06.036

Liu L, Yang W, Lu Y, Wang J, Zheng Y, Gu S. Clinical Efficacy of Tandospirone on Functional Dyspepsia Patients with Anxiety: A Randomized, Placebo-Controlled Study. Dig Dis Sci. 2023;68(2):521-8. https://doi.org/10.1007/s10620-022-07717-z

Tack J, Ly HG, Carbone F, Vanheel H, Vanuytsel T, Holvoet L, et al. Efficacy of Mirtazapine in Patients With Functional Dyspepsia and Weight Loss. Clin Gastroenterol Hepatol. 1 de marzo de 2016;14(3):385-392.e4. https://doi.org/10.1016/j.cgh.2015.09.043

Jamshidfar N, Hamdieh M, Eslami P, Batebi S, Sadeghi A, Rastegar R, et al. Comparison of the potency of nortriptyline and mirtazapine on gastrointestinal symptoms, the level of anxiety and depression in patients with functional dyspepsia. Gastroenterol Hepatol Bed Bench. 2023;16(1):468-77. https://doi.org/10.22037/ghfbb.v16i1.2513

Cao L, Li G, Cao J, Li F, Han W. Randomized clinical trial: the effects of mirtazapine in functional dyspepsia patients. Ther Adv Gastroenterol. 2025;18:17562848241311129. https://doi.org/10.1177/17562848241311129

Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353-67. https://doi.org/10.1136/gutjnl-2015-309252

Ford AC, Tsipotis E, Yuan Y, Leontiadis GI, Moayyedi P. Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis. Gut. 2022;71(10):1967-75. https://doi.org/10.1136/gutjnl-2021-326583

Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;71(9):1724-62. https://doi.org/10.1136/gutjnl-2022-327745

Lehmann A, Kahrilas PJ. Retrograde cricopharyngeus dysfunction (R-CPD), also known as inability to belch syndrome—a narrative review. Transl Gastroenterol Hepatol. 2026;11:74. https://doi.org/10.21037/tgh-2025-158

Murray HB, Juarascio AS, Di Lorenzo C, Drossman DA, Thomas JJ. Diagnosis and Treatment of Rumination Syndrome: A Critical Review. Off J Am Coll Gastroenterol ACG. 2019;114(4):562. https://doi.org/10.14309/ajg.0000000000000060

Table 1. Principal Rome V updates in gastroduodenal disorders and their clinical implications

Published

2026-09-11

How to Cite

Hanna Jairala, I. (2026). Gastroduodenal disorders of gut-brain interaction: Practical implications of Rome V in Latin America. Revista Colombiana De Gastroenterología, 41(3), 316–323. https://doi.org/10.22516/25007440.1616

Issue

Section

Review articles

Altmetric

Escanea para compartir
QR Code
Crossref Cited-by logo
Article metrics
Abstract views29
Galley views15
PDF Views15
HTML views0
Other views0

Some similar items: